As filed with the Securities and Exchange Commission...
BRIDGEWATER, N.J., Sept. 03, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...
As filed with the...
BRIDGEWATER, N.J., Aug. 29, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________...
BRIDGEWATER, N.J., Aug. 15, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C...
BRIDGEWATER, N.J., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical...
- Parkinson’s Disease Therapeutic Apomorphine Delivery via the h-Patch™ Offers Advantages Over Subcutaneous...
- Company Plans to Explore Partnering Opportunities with CBD Therapeutics Companies - - Company to Host a...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads